Safety of generic fingolimod

• Asıl Yazarlar: O. M. Koval (Yazar), N. V. Khachanova (Yazar), M. V. Zhuravleva (Yazar), A. G. Fisun (Yazar), M. V. Davydovskaya (Yazar), K. A. Kokushkin (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2018-03-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Generic drug of fingolimode (Nesklair, Russia) receives marketing authorisation in 2014. In 2016, was initiated the Post-authorisation safety study (PASS) to evaluate the safety of Neskler in patients with remitting multiple sclerosis (MS) vs. original drug and in the primary assignment. This PASS w...